Nitazoxanide and azithromycin for the early treatment of COVID‐19: A multi‐spectroscopic, biochemical and computational drug–drug interaction study
Journal of the Chinese Chemical Society · 2023-07 · 70 (7) · 1568-1579
DOI: 10.1002/jccs.202350075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Chinese Chemical Society, online erschienen am 29.04.2023. Verfasst von Syed Abid Ali und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Higher Education Commision, Pakistan.
Abstract (Originalsprache)
Herein, we present an experimental and theoretical drug–drug interaction study between nitazoxanide (NTZ) and azithromycin (AZT) in an aqueous solution. Interaction was studied by using UV/Vis, fluorescence, attenuated total reflectance‐fourier transform infrared (ATR‐FTIR), and circular dichroism (CD) spectroscopy, while molecular docking studies were performed to establish the interaction computationally. A bright yellow color was observed when the two drugs interacted, giving a hyperchromic band at 420 nm. The rate of absorbance was linearly increased by increasing drug concentrations and in a time‐dependent manner. Stability of the interaction complex (i.e., NTZ: AZT) was measured at variable temperatures (25–80°C), pH (5.0–10.0) and ionic strength (0.05–2.0 M NaCl), and not only proved stable but also retained antimicrobial potential with reduced cellular toxicity. Mole ratio and Job's method of continuous variations were used to establish the binding stoichiometry and found to be 2:1. The calculated binding constant (k b = 8,400 M −1 ) and Gibb's free energy (ΔG° = −22.4 KJ/mol) also suggested an energetically favorable interaction. FTIR spectra of NTZ: AZT complex in comparison with two drugs alone revealed significant interaction which was nicely complemented by molecular docking studies. Interaction was also successfully demonstrated in presence of carrier protein HSA and by spiking the two drugs in real samples of human plasma and urine.
Förderung
- Higher Education Commision, Pakistan
Zitieren
APA
Ali, S. A., Abid, M., Ahmed, A., Wadood, A., & Ahmed, S. (2023). Nitazoxanide and azithromycin for the early treatment of COVID‐19: A multi‐spectroscopic, biochemical and computational drug–drug interaction study. Journal of the Chinese Chemical Society, 70(7), 1568-1579. https://doi.org/10.1002/jccs.202350075
Vancouver
Ali SA, Abid M, Ahmed A, Wadood A, Ahmed S. Nitazoxanide and azithromycin for the early treatment of COVID‐19: A multi‐spectroscopic, biochemical and computational drug–drug interaction study. Journal of the Chinese Chemical Society. 2023;70(7):1568-1579. doi:10.1002/jccs.202350075
BibTeX
@article{Ali2023,
author = {Ali, Syed Abid and Abid, Muhammad and Ahmed, Ayaz and Wadood, Abdul and Ahmed, Shakil},
title = {Nitazoxanide and azithromycin for the early treatment of COVID‐19: A multi‐spectroscopic, biochemical and computational drug–drug interaction study},
journal = {Journal of the Chinese Chemical Society},
year = {2023},
volume = {70},
number = {7},
pages = {1568--1579},
doi = {10.1002/jccs.202350075}
}
EUVIMED